Patents by Inventor Jiunn Teo
Jiunn Teo has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Patent number: 11925736Abstract: Dialyzer systems can consolidate multiple technologies and functionalities of blood treatment systems in a significantly integrated fashion. For example, this disclosure describes dialyzer systems that include a magnetically driven and magnetically levitating pump rotor integrated into the dialyzer. Such a dialyzer can be used with treatment modules that include a magnetic field-generating pump drive unit. In some embodiments, the dialyzers include pressure sensor chambers with flexible membranes with which corresponding pressure transducers of the treatment modules can interface to detect arterial and/or venous pressures.Type: GrantFiled: November 12, 2020Date of Patent: March 12, 2024Assignees: Fresenius Medical Care Deutschland GmbH, Fresenius Medical Care Holdings, Inc.Inventors: Massimo Earl Fini, Lynn E. Jensen, Alexander Heide, Dejan Nikolic, Arne Peters, Christoph Wiktor, Marina Wenke, Tommy Huang, Dacey John Ryan, Stefan Kreber, Lothar Leick, Dzhuney Terzi, Hendrik Therre, Manfred Weis, Alain Veneroni, Reinhold Reiter, Michele Marini, Davide Maria Benelli, Brad Yang, Jiunn Teo
-
Patent number: 11883784Abstract: A method is disclosed for forming a microporous membrane that incorporates an additive having low water solubility at the membrane's active surface from a precipitation fluid. The incorporated additive at the membrane's active surface can improve one or more of the membrane's hydrophilicity, wettability, anti-fouling behavior, blood compatibility, and stability over long periods of use or repetitive use. The microporous membrane with this modified active surface can be a hollow fiber, flat sheet, or other self-supporting shape. The microporous membranes can be used for membrane filtering or a solute and/or solvent exchange process, which involve contacting aqueous-based fluid or blood with the microporous membrane, such processes for dialysis, blood oxygenation, or blood separation filtering, or other processes.Type: GrantFiled: April 26, 2021Date of Patent: January 30, 2024Assignee: FRESENIUS MEDICAL CARE HOLDINGS, INC.Inventors: Praveen Kosaraju, Monica P. Hall, Jiunn Teo
-
Publication number: 20220362717Abstract: The present invention relates to a method to make polymeric membranes that are preferably useful in dialysis, wherein the method conducts at least one membrane-forming step and/or post-forming processing step with the use of sonication. Polymeric membrane, such as polymeric hollow fiber membrane, having improved one or properties are further described.Type: ApplicationFiled: May 10, 2022Publication date: November 17, 2022Applicant: Fresenius Medical Care Holdings, Inc.Inventors: Brodie SCHWINN, Jiunn TEO
-
Patent number: 11499016Abstract: A polysulfone-urethane copolymer is disclosed, which can be used as a membrane polymer, e.g., a matrix polymer, a pore forming agent, or both, while enhancing a membrane's blood compatibility. Methods are disclosed for forming the copolymer and incorporating the copolymer in membranes (e.g., spun hollow fibers, flat membranes) and other products.Type: GrantFiled: October 1, 2020Date of Patent: November 15, 2022Assignee: FRESENIUS MEDICAL CARE HOLDINGS, INC.Inventors: Geoffrey Russell, James White, Jiunn Teo, Kevin Hudson, Monica Hall, Praveen Kosaraju
-
Publication number: 20220133967Abstract: A hollow fiber membrane and methods of making the hollow fiber membrane are described. The membrane includes a hydrophobic polymer such as polysulfone, a hydrophilic polymer such as polyvinylpyrrolidone (PVP), and a fluropolymer additive, and optionally a stabilizer, for instance, to stabilize the fluoropolymer additive in the membrane, particularly during conditioning or E-beam sterilization or both. Further conditioning improvements to membrane manufacturing are disclosed. The membrane may be incorporated into a dialysis filter for use in hemodialysis and related applications. The membrane has improved hemocompatibility, charge stability, or middle molecule clearance compared to conventional membranes. Also disclosed is a method of evaluating membrane charge stability.Type: ApplicationFiled: October 28, 2021Publication date: May 5, 2022Applicant: Fresenius Medical Care Holdings, Inc.Inventors: Hui SHAO, Jiunn TEO, Chih-Hu HO
-
Publication number: 20210245108Abstract: A method is disclosed for forming a microporous membrane that incorporates an additive having low water solubility at the membrane's active surface from a precipitation fluid. The incorporated additive at the membrane's active surface can improve one or more of the membrane's hydrophilicity, wettability, anti-fouling behavior, blood compatibility, and stability over long periods of use or repetitive use. The microporous membrane with this modified active surface can be a hollow fiber, flat sheet, or other self-supporting shape. The microporous membranes can be used for membrane filtering or a solute and/or solvent exchange process, which involve contacting aqueous-based fluid or blood with the microporous membrane, such processes for dialysis, blood oxygenation, or blood separation filtering, or other processes.Type: ApplicationFiled: April 26, 2021Publication date: August 12, 2021Applicant: Fresenius Medical Care Holdings, Inc.Inventors: Praveen Kosaraju, Monica P. Hall, Jiunn Teo
-
Patent number: 11014051Abstract: A method is disclosed for forming a microporous membrane that incorporates an additive having low water solubility at the membrane's active surface from a precipitation fluid. The incorporated additive at the membrane's active surface can improve one or more of the membrane's hydrophilicity, wettability, anti-fouling behavior, blood compatibility, and stability over long periods of use or repetitive use. The microporous membrane with this modified active surface can be a hollow fiber, flat sheet, or other self-supporting shape. The microporous membranes can be used for membrane filtering or a solute and/or solvent exchange process, which involve contacting aqueous-based fluid or blood with the microporous membrane, such processes for dialysis, blood oxygenation, or blood separation filtering, or other processes.Type: GrantFiled: September 10, 2018Date of Patent: May 25, 2021Assignee: FRESENIUS MEDICAL CARE HOLDINGS, INC.Inventors: Praveen Kosaraju, Monica P. Hall, Jiunn Teo
-
Publication number: 20210138131Abstract: Dialyzer systems can consolidate multiple technologies and functionalities of blood treatment systems in a significantly integrated fashion. For example, this disclosure describes dialyzer systems that include a magnetically driven and magnetically levitating pump rotor integrated into the dialyzer. Such a dialyzer can be used with treatment modules that include a magnetic field-generating pump drive unit. In some embodiments, the dialyzers include pressure sensor chambers with flexible membranes with which corresponding pressure transducers of the treatment modules can interface to detect arterial and/or venous pressures.Type: ApplicationFiled: November 12, 2020Publication date: May 13, 2021Inventors: Massimo Earl Fini, Lynn E. Jensen, Alexander Heide, Dejan Nikolic, Arne Peters, Christoph Wiktor, Marina Wenke, Tommy Huang, Dacey John Ryan, Stefan Kreber, Lothar Leick, Dzhuney Terzi, Hendrik Therre, Manfred Weis, Alain Veneroni, Reinhold Reiter, Michele Marini, Davide Benelli, Brad Yang, Jiunn Teo
-
Patent number: 10961340Abstract: A method forming a surface modifying composition with reduced need for organic solvent and evaporation thereof for removal of insoluble reaction byproducts from the composition. The purified composition can be used in the formation of articles having improved biocompatibility, such as medical articles (e.g., spun hollow fiber).Type: GrantFiled: July 12, 2018Date of Patent: March 30, 2021Assignee: FRESENIUS MEDICAL CARE HOLDINGS, INC.Inventors: Jiunn Teo, Craig Kamerath, Praveen Kosaraju, Monica P. Hall
-
Publication number: 20210017340Abstract: A polysulfone-urethane copolymer is disclosed, which can be used as a membrane polymer, e.g., a matrix polymer, a pore forming agent, or both, while enhancing a membrane's blood compatibility. Methods are disclosed for forming the copolymer and incorporating the copolymer in membranes (e.g., spun hollow fibers, flat membranes) and other products.Type: ApplicationFiled: October 1, 2020Publication date: January 21, 2021Applicant: Fresenius Medical Care Holdings, Inc.Inventors: Geoffrey Russell, James White, Jiunn Teo, Kevin Hudson, Monica Hall, Praveen Kosaraju
-
Patent number: 10822461Abstract: A polysulfone-urethane copolymer is disclosed, which can be used as a membrane polymer, e.g., a matrix polymer, a pore forming agent, or both, while enhancing a membrane's blood compatibility. Methods are disclosed for forming the copolymer and incorporating the copolymer in membranes (e.g., spun hollow fibers, flat membranes) and other products.Type: GrantFiled: September 28, 2018Date of Patent: November 3, 2020Assignee: FRESENIUS MEDICAL CARE HOLDINGS, INC.Inventors: Geoffrey Russell, James White, Jiunn Teo, Kevin Hudson, Monica Hall, Praveen Kosaraju
-
Publication number: 20190106545Abstract: A polysulfone-urethane copolymer is disclosed, which can be used as a membrane polymer, e.g., a matrix polymer, a pore forming agent, or both, while enhancing a membrane's blood compatibility. Methods are disclosed for forming the copolymer and incorporating the copolymer in membranes (e.g., spun hollow fibers, flat membranes) and other products.Type: ApplicationFiled: September 28, 2018Publication date: April 11, 2019Applicant: Fresenius Medical Care Holdings, Inc.Inventors: Geoffrey Russell, James White, Jiunn Teo, Kevin Hudson, Monica Hall, Praveen Kosaraju
-
Publication number: 20190076787Abstract: A method is disclosed for forming a microporous membrane that incorporates an additive having low water solubility at the membrane's active surface from a precipitation fluid. The incorporated additive at the membrane's active surface can improve one or more of the membrane's hydrophilicity, wettability, anti-fouling behavior, blood compatibility, and stability over long periods of use or repetitive use. The microporous membrane with this modified active surface can be a hollow fiber, flat sheet, or other self-supporting shape. The microporous membranes can be used for membrane filtering or a solute and/or solvent exchange process, which involve contacting aqueous-based fluid or blood with the microporous membrane, such processes for dialysis, blood oxygenation, or blood separation filtering, or other processes.Type: ApplicationFiled: September 10, 2018Publication date: March 14, 2019Applicant: Fresenius Medical Care Holdings, Inc.Inventors: Praveen Kosaraju, Monica P. Hall, Jiunn Teo
-
Publication number: 20190016845Abstract: A method forming a surface modifying composition with reduced need for organic solvent and evaporation thereof for removal of insoluble reaction byproducts from the composition. The purified composition can be used in the formation of articles having improved biocompatibility, such as medical articles (e.g., spun hollow fiber).Type: ApplicationFiled: July 12, 2018Publication date: January 17, 2019Applicant: Fresenius Medical Care Holdings, Inc.Inventors: Jiunn Teo, Craig Kamerath, Praveen Kosaraju, Monica P. Hall
-
Patent number: 9617421Abstract: The present invention relates to the use of additives in processes to form polymeric fibers. These fibers can be formed into membranes with improved middle and/or higher molecular weight solute removal.Type: GrantFiled: February 3, 2012Date of Patent: April 11, 2017Assignee: Fresenius Medical Care Holdings, Inc.Inventors: Cheryl Ford, Jiunn Teo, Leslie Schmidt
-
Patent number: 9353220Abstract: A process for making polyarylethers provides a reaction mixture that includes a dipolar aprotic solvent for polyarylether and polyarylether forming reactants, and reacts the polyarylether-forming reactants, with removing of water with nitrogen in the absence of azeotrope forming cosolvent and optionally replacing removed amounts with dipolar aprotic solvent. The process can further include directly wet spinning the reactor solution without recovery of the polymer from the dipolar aprotic solvent through a spinneret to form hollow fibers or flat sheets suitable for membranes.Type: GrantFiled: August 13, 2013Date of Patent: May 31, 2016Assignee: Fresenius Medical Care Holdings, Inc.Inventors: Selvaraj Savariar, Kevin Hudson, Geoffrey Andrew Russell, James Leslie White, Brett Allen Barton, Cheryl Ford, Jiunn Teo
-
Publication number: 20130338297Abstract: The present invention relates to the use of additives in processes to form polymeric fibers. These fibers can be formed into membranes with improved middle and/or higher molecular weight solute removal.Type: ApplicationFiled: February 3, 2012Publication date: December 19, 2013Inventors: Cheryl Ford, Jiunn Teo, Leslie Schmidt
-
Patent number: RE48703Abstract: The present invention relates to the use of additives in processes to form polymeric fibers. These fibers can be formed into membranes with improved middle and/or higher molecular weight solute removal.Type: GrantFiled: December 27, 2018Date of Patent: August 24, 2021Assignee: FRESENIUS MEDICAL CARE HOLDINGS, INC.Inventors: Cheryl Ford, Jiunn Teo, Leslie Schmidt
-
Patent number: RE50084Abstract: The present invention relates to the use of additives in processes to form polymeric fibers. These fibers can be formed into membranes with improved middle and/or higher molecular weight solute removal.Type: GrantFiled: July 9, 2021Date of Patent: August 20, 2024Assignee: FRESENIUS MEDICAL CARE HOLDINGS, INC.Inventors: Cheryl Ford, Jiunn Teo, Leslie Schmidt